Abstract: This invention relates to bacteria of the genus Pseudoxanthomonas and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4657, capable of degrading MTBE and/or TBA. The invention also relates to a process for treatment of an effluent comprising MTBE and optionally TBA using such bacteria.

Abstract: This invention relates to bacteria of the genus Pseudonocardia, and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4656, capable of degrading MTBE and/or ETBE. The invention also relates to a process for treatment of an effluent comprising MTBE and/or ETBE and optionally TBA that uses such bacteria.

Abstract: This invention relates to bacteria of the genus Pseudoxanthomonas and in particular the strain deposited on Jul. 12, 2012 at the Pasteur Institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS Cedex 15, France) under No. CNCM 1-4657, capable of degrading MTBE and/or TBA. The invention also relates to a process for treatment of an effluent comprising MTBE and optionally TBA using such bacteria.

Abstract: This invention relates to new Rhodococcus wratislaviensis CNCM I-4088 bacteria or Rhodococcus aetherivorans CNCM I-4089 bacteria that can degrade multiple petroleum compounds in solution in aqueous effluents. The invention also relates to a process for treating aqueous effluents comprising a complex mixture of substances containing native hydrocarbons of gasolines and additives that are present in gasolines or diesel fuel, in which process said bacteria are grown under aerobic conditions in the presence of a growth substrate containing said mixture as a carbon source, and said mixture is at least partially degraded by the bacteria down to the final degradation products—carbon dioxide, water and biomass.

Abstract: The invention concerns an isolated or purified polypeptide having an activity in the MTBE degradation path, and/or at least one of the catabolic intermediates of MTBE, preferably selected from the group consisting of tert-butyl alcohol (TBA), 2-methyl 1,2-propanediol (2-M1, 2-PD), hydroxyisobutyraldehyde, hydroxyiso-butyric acid (HIBA), said polypeptide being selected from the group consisting of: a) a polypeptide comprising a sequence of amino acids selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:10; b) a polypeptide comprising a sequence of amino acids having at least 70% identity, preferably 75%, 80%, 90%, 95%, 98% or 99% with the sequence of amino acids of a polypeptide as defined in a); a polypeptide as defined in a) or b) whereof the sequence of amino acids comprises a substitution, deletion, insertion, addition or mutation of one or several amino acids over its entire length.

Abstract: The invention concerns an isolated or purified polypeptide having an activity in the MTBE degradation path, and/or at least one of the catabolic intermediates of MTBE, preferably selected from the group consisting of tert-butyl alcohol (TBA), 2-methyl 1,2-propanediol (2-M1, 2-PD), hydroxyisobutyraldehyde, hydroxyiso-butyric acid (HIBA), said polypeptide being selected from the group consisting of: a) a polypeptide comprising a sequence of amino acids selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:10; b) a polypeptide comprising a sequence of amino acids having at least 70% identity, preferably 75%, 80%, 90%, 95%, 98% or 99% with the sequence of amino acids of a polypeptide as defined in a); a polypeptide as defined in a) or b) whereof the sequence of amino acids comprises a substitution, deletion, insertion, addition or mutation of one or several amino acids over its entire length.

Abstract: To reduce the concentration of methyl tert-butyl ether (MTBE) or tert-amyl methyl ether (TAME) in an aquifer polluted by these ethers, a new mineral support for fixing bacteria, and in particular Mycobacterium austroafricanum I-2562, said mineral support comprising perlite, is used in a biobarrier- or biofilter-type process.

Abstract: A process for the treatment of aqueous effluents containing at least one of the following ethers is described: ethyl tert-butyl ether (ETBE) and/or methyl tert-butyl ether (MTBE) and/or tert-amyl methyl ether (TAME) in order to reduce the concentration of these ethers. A bacterium Gordonia terrae CIP I-2194 is innoculated under aerobic conditions. In particular, a bacterium Burkholderia cepacia CIP I-2052 or a bacterium Alcaligenes sp. CIP I-2561 or a bacterium Mycobacterium sp. CIP I-2562 is added in the presence of a growth substrate and, optionally, of a cobalt salt, and the ether contained in the effluents is degraded by the bacteria thus innoculated until its mineralization. The process is useable in the ether-contaminated water treatment industry.

Abstract: A process for treatment of aqueous effluents, for example, an aquifer, that contains at least methyl-tert-butyl ether (MTBE) or methyl-tert-amyl ether (TAME) so as to reduce the concentration of said ether is described, characterized in that a Mycobacterium austroafricanum I-2562 bacterium is grown under aerobic conditions in the presence of a growth substrate that contains said ether, and said ether is degraded by said bacterium down to the final degradation products, carbon dioxide and water. The results are improved in the presence of yeast extract.

Abstract: To reduce the concentration of methyl tert-butyl ether (MTBE) or tert-amyl methyl ether (TAME) in an aquifer polluted by these ethers, a new mineral support for fixing bacteria, and in particular Mycobacterium austroafricanum I-2562, said mineral support comprising perlite, is used in a biobarrier- or biofilter-type process.

Abstract: The growth of the bacterium, Burkholderia cepacia (ex Pseudomonas cepacia) CIP 1-2052 is substantially increased when it is supplied with tert-butanol (TBA) or tert-amyl alcohol (TAA) as the sole source of carbon and energy in the presence of at least one cobalt salt, at a concentration of 0.01 to 4 mg/l of medium. The bacterium is degraded to CO2 in the presence of oxygen. The inoculom produced by the process and the degradation process for these alcohols are useful for water treatment applications.

Abstract: A process for treatment of aqueous effluents that contain at least methyl-tert-butyl ether (MTBE) or methyl-tert-amyl ether (TAME) so as to reduce the concentration of said ether is described, characterized in that a Mycobacterium austroafricanum I-2562 bacterium is grown under aerobic conditions in the presence of a growth substrate that contains said ether, and said ether is degraded by said bacterium down to the final degradation products, carbon dioxide and water. The results are improved in the presence of yeast extract.

Abstract: A process for treating aqueous effluents that contain ethyl-tert-butyl ether (ETBE) to reduce the ETBE concentration is described, characterized in that in the presence of effluents, at least one bacterium that is selected from the group that is formed by Gordona terrae CIP I-1889 and Rhodococcus equi CIP I-2053 and in the presence of at least one bacterium that is selected from the group that is formed by Pseudomonas cepacia CIP 1-2052, Arthrobacter globiformis ATCC 53596, Bacillus coagulans ATCC 53595, Pseudomonas stutzerii ATCC 53602 and Mycobacterium vaccae JOB5 are grown to degrade essentially all of the ETBE. The concentration of ETBE in the effluent is equal to at most 1500 mg/L. Application for the water treatment industry.

Abstract: The Clostridium acetobutylicum mutant IFP 904 (ATCC 39058) is obtained by spreading a culture of a strain of Clostridium acetobutylicum at the surface of a solid culture medium containing n-butanol at a specified concentration, growing the strain in the presence of a mutagenic agent and recovering a strain of increased resistance to n-butanol. The resultant mutant can be used to produce a mixture of butanol and acetone of increased concentration.